- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Banking and Institutional Finance
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Franchise and Hospitality
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Buy American
- COVID-19 Vaccine Rollout
- Crisis Management
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- The New Administration: Enforcement and Legislative Impact
- Careers
- News & Insights
- About
- Languages
Thomas J. Spulak
Events 31 results
Webinar
November 9, 2021
King & Spalding Pharmaceutical University 2021
Webinar
March 29, 2021
The Return of Congressional Earmarks
Webinar
February 16, 2021
Budget Reconciliation—A Conversation with Peter Robinson, Former Senate Senior Assistant Parliamentarian
Webinar
February 4, 2021
A Sea Change: Environmental Enforcement
Speaking Engagement
December 1, 2020
Tom Spulak to Speak at ACI’s 2nd National Forum on FARA
Webinar
October 7, 2020
11th Annual ACC CLE Jamboree
Webinar
May 21, 2020
Congressional Investigations: A Bipartisan Conversation With Chief Counsels During the COVID-19 Pandemic
Webinar
April 22, 2020
COVID-19 Issues for Manufacturers
Webinar
April 3, 2020
Latest Congressional and CMS Actions Related to COVID-19
Webinar
March 27, 2020
Impact of Congressional Actions Related to COVID-19 on Healthcare Providers
Webinar
January 30, 2020
Congress 2020: The Year Ahead
Webinar
September 12, 2019
Open Borders for Rx Drugs? The Trump Administration’s Move to Authorize Prescription Drug Importation